World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
141
Citations
97292
World Ranking
1591
National Ranking
40

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Fabrice Andre is affiliated with Institut Gustave Roussy in France and has contributed extensively to the field of medical research, particularly within oncology and molecular biology.

Their research spans several main fields of study including Medicine and Biochemistry, Genetics, and Molecular Biology. Within these, they focus on subfields such as Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, and Genetics.

The major topics covered by their work include Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers, and Lung Cancer Treatments and Mutations.

Fabrice Andre has published papers in a range of frequent venues, predominantly in Annals of Oncology, Cancer Research, Journal of Clinical Oncology, ESMO Open, and Clinical Cancer Research.

Recent notable papers include:

  • 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5), 2020, Annals of Oncology
  • ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer, 2021, Annals of Oncology
  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group, 2020, Annals of Oncology
  • Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19, 2020, Cell
  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021, 2021, Annals of Oncology

Their research collaborations include frequent co-authors such as Barbara Pistilli, Stefan Michiels, Inês Vaz-Luís, Antonio Di Meglio, and Sibille Everhard.

Best Publications

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

    Cornelia Liedtke;Chafika Mazouni;Kenneth R. Hess;Fabrice André

  • Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

    Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Michel Obeid;Michel Obeid;Michel Obeid

  • DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

    Ken A. Olaussen;Ariane Dunant;Pierre Fouret;Elisabeth Brambilla

  • Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    François Ghiringhelli;Lionel Apetoh;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Laetitia Aymeric;Laetitia Aymeric;Laetitia Aymeric

  • Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer

    Fabrice André;Eva Ciruelos;Gabor Rubovszky;Mario Campone

  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    F. Cardoso;A. Costa;E. Senkus;M. Aapro

  • Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

    Gabriel N. Hortobagyi;Salomon M. Stemmer;Howard A. Burris;Yoon-Sim Yap

  • AACR project genie: Powering precision medicine through an international consortium

    S. M. Sweeney;E. Cerami;A. Baras;T. J. Pugh

  • Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

    Nicholas C. Turner;Jungsil Ro;Fabrice André;Sherene Loi

  • Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

    Shanu Modi;Cristina Saura;Toshinari Yamashita;Yeon Hee Park

  • Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

    Bernard Escudier;Thierry Dorval;Nathalie Chaput;Fabrice André

  • Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

    Carsten Denkert;Gunter von Minckwitz;Jan C. Brase;Bruno V. Sinn

  • Malignant effusions and immunogenic tumour-derived exosomes

    Fabrice Andre;Noel E C Schartz;Mojgan Movassagh;Caroline Flament

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba

  • Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

    Nicholas C Turner;Dennis J Slamon;Jungsil Ro;Igor Bondarenko

  • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

    Lyndsay N. Harris;Nofisat Ismaila;Lisa M. McShane;Fabrice Andre

  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.

    F. Mosele;J. Remon;J. Mateo;C. B. Westphalen

  • ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

    C. Luchini;F. Bibeau;M.J.L. Ligtenberg;N. Singh

Frequent Co-Authors

Suzette Delaloge
Suzette Delaloge Institut Gustave Roussy
Jean-Charles Soria
Jean-Charles Soria Amgen (United States)
Stefan Michiels
Stefan Michiels University of Paris-Saclay
Sherene Loi
Sherene Loi Peter MacCallum Cancer Centre
Mario Campone
Mario Campone Grenoble Alpes University
Sibylle Loibl
Sibylle Loibl Goethe University Frankfurt
Lajos Pusztai
Lajos Pusztai Yale University
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Giuseppe Curigliano
Giuseppe Curigliano University of Milan
Benjamin Besse
Benjamin Besse University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The field of medicine offers numerous online degree options and career pathways beyond becoming a doctor. Those interested in pharmacy can explore online pharmd programs, which prepare graduates for advanced roles in pharmaceutical care and research while offering flexibility for working professionals.

For those drawn to the intersection of healthcare and technology, healthcare informatics degree programs train students to manage patient data and healthcare information systems—crucial skills in today’s digital health landscape.

Another popular pathway is medical administration. medical billing and coding classes online offer the expertise needed to work with healthcare records and insurance claims, with the added convenience of online study.

Lastly, if you’re looking to advance in nursing, consider the cheapest online fnp program. Family Nurse Practitioners play a vital role in primary care, and online programs make career progression more accessible and affordable.

Best Scientists Citing Fabrice Andre

Trending Scientists